Medicus Pharma Appoints Carolyn Bonner as CFO and President

Medicus Pharma Ltd., a biotech company listed on NASDAQ, has appointed Carolyn Bonner as Chief Financial Officer, in addition to her continuing role as President. Bonner, who has been acting as CFO since September, succeeds James Quinlan, who resigned due to health issues. Dr. Raza Bokhari, CEO of Medicus, highlighted Bonner's strong financial leadership and her expanded role to ensure operational integration as the company progresses with its clinical developments.

Bonner's experience spans nearly two decades in the healthcare and life sciences sectors. Her responsibilities now include overseeing financial reporting, capital markets strategy, and strategic planning. Under her leadership, Medicus advances its clinical pipeline, including projects like SkinJect's non-invasive treatment for basal cell carcinoma in clinical trials in the US, UAE, and the UK.